SCHEMBL9254801

SCHEMBL9254801

Cc1ccc(-c2occc2C#N)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP2A6 P11509 1/20 0.40
MAOA P21397 4/20 0.39
LRRK2 Q5S007 1/20 0.39
MAOB P27338 4/20 0.37
ERBB2 P04626 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
PDK1 Q15118 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
KDM4E B2RXH2 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31358675 0.80 CHRM2 (0.42) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9254209 0.77 CHRM2 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL23566743 0.73 ACHE (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL2614471 0.70
SCHEMBL8866488 0.70 AR (0.50) ARCHRM2CHRM4CHRM5CHRM1
SCHEMBL28155485 0.69 CASP3 (0.42) ALDH1A1KDM4ESMN1; SMN2L3MBTL1MEN1
SCHEMBL9587935 0.69 ALDH1A1 (0.40) ARCHRM2CHRM4CHRM5CHRM1
SCHEMBL9251205 0.69 MAOB (0.42) ARALDH1A1CYP2A6MAOALRRK2
SCHEMBL19608809 0.65 AR (0.53) ARALDH1A1CYP2A6MAOALRRK2
SCHEMBL18406716 0.65 AR (0.62) ARALDH1A1CYP2A6MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5389632-A Cardiovascular disorders LABORATOIRES UPSA (FR) 1995-02-14 US disclosed
US-5387747-A Used in the treatment and prevention of cardiovascular diseases: hypertension, cardiac insufficiency and atherosclerosis LABORATOIRES UPSA (FR) 1995-02-07 US disclosed